Asked by: Jas Athwal (Labour - Ilford South)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve the quality of medical care available to people with learning disabilities.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
Significant action is underway to improve access to and the quality of care for people with a learning disability. This will help deliver the shift from treatment to prevention, outlined in our 10-Year Health Plan, with further information avaiable at the following link:
https://www.gov.uk/government/publications/10-year-health-plan-for-england-fit-for-the-future
As part of this we are rolling out mandatory training for health and social care staff, improving identification on the general practice learning disability register and uptake of annual health checks, and implementing a Reasonable Adjustment Digital Flag in health and care records to ensure care is tailored appropriately. The NHS Learning Disability Improvement Standard also supports trusts by setting guidance on safe, personalised, and high-quality care provision. The standards are designed to support organisations in assessing the quality of their services and to promote uniformity across the National Health Service in the care and treatment provided to people with a learning disability. Further information on the standards is avaiable at the following link:
Each integrated care board must also have an executive lead for learning disability and autism and must demonstrate how they will reduce inequalities for people with a learning disability within their five year strategic plans under the Medium-Term Planning Framework. Further information is avaiable on the Medium-Term Planning Framework at the following link:
Asked by: Alison Bennett (Liberal Democrat - Mid Sussex)
Question to the Home Office:
To ask the Secretary of State for the Home Department, whether migrant workers employed in the social care sector will be subject to the same settlement routes and qualifying periods as counterparts working in the NHS under the Health and Care visa.
Answered by Mike Tapp - Parliamentary Under-Secretary (Home Office)
The earned settlement model, proposed in ‘A Fairer Pathway to Settlement’, announced changes to the mandatory requirements and qualifying period for indefinite leave to remain. It is currently subject to a public consultation, running until 12 February 2026.
The consultation seeks views on the impact proposed changes might have on different groups. Details of the earned settlement model will be finalised following that consultation.
The final model will also be subject to economic and equality impact assessments, which we have committed to publish in due course.
Asked by: Bobby Dean (Liberal Democrat - Carshalton and Wallington)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what discussions his Department has had with UKRI and the National Institute for Health and Care Research on supporting new and emerging treatments for low‑grade gliomas.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department invests over £1.6 billion per year in research through the National Institute for Health and Care Research (NIHR).
Government responsibility for delivering cancer research is shared between Department for Health and Social Care, with research delivered by the NIHR, and Department for Science, Innovation and Technology, with research delivered via UK Research and Innovation.
Department of Health and Social Care and Department of Science, Innovation and Technology officials meet regularly to discuss a range of research investments to drive the maximum collective research impact on policy, practice, and individual lives.
The NIHR is continuing to invest in brain tumour research. In December 2025, the NIHR announced the pioneering Brain Tumour Research Consortium to accelerate research into new brain tumour treatments. NIHR is investing an initial £13.7 million in the consortium, with significant further funding due to be awarded early in 2026. The world-leading consortium aims to transform outcomes for adults and children and their families who are living with brain tumours, ultimately reducing lives lost to cancer.
The NIHR continues to welcome high quality funding applications for research into any aspect of human health and care, including low-grade glioma.
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent estimate his Department has made of levels of medicine wastage in the NHS.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government recognises the importance of a coordinated approach to reduce medicine wastage, improve efficiencies, and lower costs for taxpayers.
NHS England leads a medicine optimisation programme to enhance patient outcomes, ensure medication is taken as intended, avoid unnecessary medicines, and reduce wastage. For example, community pharmacies offer the New Medicines Service for newly prescribed patients and the Discharge Medicines Service for those recently discharged from hospital to support adherence.
The 2021 national overprescribing review highlighted necessary practical and cultural changes to ensure appropriate patient treatment and value for money. General practices offer Structured Medicine Reviews, with pharmacists in multi-disciplinary teams optimising patient medication and preventing wastage. Additionally, electronic Repeat Dispensing allows prescribers to send repeat prescriptions as a batch to allow better management, ensuring patients only collect what they need.
Waste reduction schemes are commissioned locally, and therefore the Department does not hold data centrally on the cost of medicines waste.
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what data his Department holds on the cost to the NHS of wasted medicines.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government recognises the importance of a coordinated approach to reduce medicine wastage, improve efficiencies, and lower costs for taxpayers.
NHS England leads a medicine optimisation programme to enhance patient outcomes, ensure medication is taken as intended, avoid unnecessary medicines, and reduce wastage. For example, community pharmacies offer the New Medicines Service for newly prescribed patients and the Discharge Medicines Service for those recently discharged from hospital to support adherence.
The 2021 national overprescribing review highlighted necessary practical and cultural changes to ensure appropriate patient treatment and value for money. General practices offer Structured Medicine Reviews, with pharmacists in multi-disciplinary teams optimising patient medication and preventing wastage. Additionally, electronic Repeat Dispensing allows prescribers to send repeat prescriptions as a batch to allow better management, ensuring patients only collect what they need.
Waste reduction schemes are commissioned locally, and therefore the Department does not hold data centrally on the cost of medicines waste.
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reduce medicine wastage in the NHS.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government recognises the importance of a coordinated approach to reduce medicine wastage, improve efficiencies, and lower costs for taxpayers.
NHS England leads a medicine optimisation programme to enhance patient outcomes, ensure medication is taken as intended, avoid unnecessary medicines, and reduce wastage. For example, community pharmacies offer the New Medicines Service for newly prescribed patients and the Discharge Medicines Service for those recently discharged from hospital to support adherence.
The 2021 national overprescribing review highlighted necessary practical and cultural changes to ensure appropriate patient treatment and value for money. General practices offer Structured Medicine Reviews, with pharmacists in multi-disciplinary teams optimising patient medication and preventing wastage. Additionally, electronic Repeat Dispensing allows prescribers to send repeat prescriptions as a batch to allow better management, ensuring patients only collect what they need.
Waste reduction schemes are commissioned locally, and therefore the Department does not hold data centrally on the cost of medicines waste.
Asked by: Alex Brewer (Liberal Democrat - North East Hampshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what guidance his Department provides on the minimum training and professional standards required for healthcare professionals undertaking child protection medicals for safeguarding assessments.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
Standards of proficiency, conduct, and performance of registered professionals are the statutory responsibility of healthcare regulators, such as the General Medical Council for doctors and the Nursing and Midwifery Council for nurses and midwives, which are independent of the Government. Approved Education Institutions and practice partners develop the specific content and design of training programmes to meet these standards. Training programmes are then approved and monitored by the relevant regulator. Practice partners provide practice placements for healthcare students and can include National Health Service trusts, social care, voluntary organisations, and general practices.
Asked by: Al Pinkerton (Liberal Democrat - Surrey Heath)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the ambulance costs from road collisions in Surrey in the past five years.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
No specific estimation has been made. Data on the number of road traffic collisions is collected and published by the Department for Transport.
Ambulance services do not routinely report costs at the level of individual incident types. However, the most recent National Cost Collection indicates that the average cost of an ambulance ‘see, treat and convey’ response is approximately £489.
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps are being taken to improve the time taken for red flag referrals for breast cancer to be seen.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
It is a priority for the Government to support the National Health Service to diagnose cancer, including breast cancer, as early and quickly as possible, and to treat it faster, to improve outcomes for all patients across England.
The Department is responsible for healthcare in England and therefore has not made a formal assessment on the timescales for red flag referrals for breast cancer across the whole of the United Kingdom.
As the first step to ensuring early diagnosis and treatment in England, NHS England has delivered an extra 100,000 operations, scans, and appointments each week since the start of this administration. This is supported by an increase in capacity to meet the demand for diagnostic services through investment in new magnetic resonance imaging and computed tomography scanners.
The Department recognises that there is more to be done to ensure that patients have timely access to diagnosis, and remains committed to diagnosing all cancer types earlier, including breast cancer. To tackle late diagnoses, the NHS is implementing non-specific symptom pathways for patients who present with symptoms such as weight loss and fatigue, which do not clearly align to a tumour type.
Reducing variation in cancer care in England, including the movement of patients through breast cancer care pathways, is a priority for the Government. To address this, NHS England funded audits into primary and metastatic breast cancer. Using routine data collected on patients diagnosed with breast cancer in an NHS setting, the audits bring together information to look at what is being done well, where it is being done well, and what needs to be done better. On 11 September 2025, the second State of the Nation report for primary and metastatic breast cancer was published by the National Cancer Audit Collaborating Centre, and officials in the Department and NHS England are acting on the findings where appropriate.
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment has been made on the timescales for red flag referrals for breast cancer across the UK.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
It is a priority for the Government to support the National Health Service to diagnose cancer, including breast cancer, as early and quickly as possible, and to treat it faster, to improve outcomes for all patients across England.
The Department is responsible for healthcare in England and therefore has not made a formal assessment on the timescales for red flag referrals for breast cancer across the whole of the United Kingdom.
As the first step to ensuring early diagnosis and treatment in England, NHS England has delivered an extra 100,000 operations, scans, and appointments each week since the start of this administration. This is supported by an increase in capacity to meet the demand for diagnostic services through investment in new magnetic resonance imaging and computed tomography scanners.
The Department recognises that there is more to be done to ensure that patients have timely access to diagnosis, and remains committed to diagnosing all cancer types earlier, including breast cancer. To tackle late diagnoses, the NHS is implementing non-specific symptom pathways for patients who present with symptoms such as weight loss and fatigue, which do not clearly align to a tumour type.
Reducing variation in cancer care in England, including the movement of patients through breast cancer care pathways, is a priority for the Government. To address this, NHS England funded audits into primary and metastatic breast cancer. Using routine data collected on patients diagnosed with breast cancer in an NHS setting, the audits bring together information to look at what is being done well, where it is being done well, and what needs to be done better. On 11 September 2025, the second State of the Nation report for primary and metastatic breast cancer was published by the National Cancer Audit Collaborating Centre, and officials in the Department and NHS England are acting on the findings where appropriate.